Total income was US$67.0 million, in comparison to US$80.2 million in the first quarter of Fiscal Year 2015 , due mainly to negative FX impact. Licensing and royalty income also declined in comparison to a year ago. On a continuous currency basis, product income was down by a low-single-digit %age y-o-y. Product income gross margin was 74 percent, in comparison to 71 percent in Q1 FY15 and Q4 FY15. This gross margin improvement was primarily powered by higher DES gross margin through a far more vertical integrated production procedure.Our Biomerk Tumorgraft models provide a more predictive preclinical system to enhance and accelerate oncology drug development. Evaluations in our Tumorgraft models are anticipated to enable the identification of the most promising development path by concentrating on indication, drug combinations, target individual populations and biomarker discovery.’.. Cervical collars excellent in reduction and immobilization of pressure Ossur, an emerging innovator in the noninvasive orthopaedics market following many acquisitions and a period of integration, offers announced that the Journal of Trauma offers published the long-awaited results of a two season cervical collar study performed by the Mayo Clinic.